pI: 5.6057 |
Length (AA): 1485 |
MW (Da): 171650 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
9 | 277 | 4mu6 (A) | 6 | 298 | 12.00 | 0.2 | 0 | 0.240045 | -0.21 |
19 | 846 | 1wxr (A) | 148 | 999 | 12.00 | 0 | 0.02 | 0.238376 | 1.66 |
56 | 278 | 4tql (A) | 14 | 235 | 10.00 | 0.1 | 0 | 0.301068 | -0.93 |
181 | 1070 | 5xus (A) | 26 | 965 | 17.00 | 0 | 0.95 | 0.375127 | 1.3 |
538 | 802 | 4o87 (A) | 13 | 319 | 28.00 | 0.069 | 0.14 | 0.214451 | 0.48 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | 4 hs Ring, Female gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Gametocyte, 16 hs Trophozoite, 22 hs Schizont, Erthyrocytic stages, Male gametocyte. | Otto TD Yeoh LM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Ookinete. | Otto TD |
Otto TD | A comprehensive evaluation of rodent malaria parasite genomes and gene expression. |
Yeoh LM | Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates. |
Ortholog group members (OG5_153590)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_IV011830 | hypothetical protein |
Plasmodium berghei | PBANKA_1453700 | AP2 domain transcription factor, putative |
Plasmodium falciparum | PF3D7_1239200 | AP2 domain transcription factor, putative |
Plasmodium knowlesi | PKNH_1459000 | AP2 domain transcription factor, putative |
Plasmodium vivax | PVX_100910 | transcription factor with AP2 domain(s), putative |
Plasmodium yoelii | PY06790 | ERYTHROCYTE MEMBRANE PROTEIN PFEMP3 |
Theileria parva | TP01_1126 | hypothetical protein |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Escherichia coli | Dihydrofolate reductase type 1 | 157 aa | 23.6% | 140 aa | Compounds | References |